After excluding 7 articles [19,23,30–33,35] which were the key contributors to between-study heterogeneity, the SMD of high adiponectin level was associated with decreased breast cancer risk (I2=54.6%, SMD = -0.348, 95% CI= -0.533--0.164). The gene discussed is ADIPOQ; the disease is breast carcinoma.